Skip to content
52
PricingSign in

Connections

Daiichi Sankyo, Inc.

87 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.

Start with
and connect to

Browse all held record sources

Zoom to read. Drag to explore. Select a connection.

Daiichi Sankyo, Inc.

Federal lobbying records

Open page
Daiichi Sankyo, Inc.: all 54 bills it lobbied on and all 32 lawmakers it gave to or whose bills it lobbied on. Point at anyone to see how they are linked.Includes 5 other records under the same name, such as its political action committee and state lobbying filings.

Every link on this map

The same connections as a table, with the reason each one is here.

Connections of Daiichi Sankyo, Inc.
HR 946Bills it lobbied onDaiichi Sankyo, Inc. named HR 946, “ORPHAN Cures Act”, in 13 lobbying reports.13 reports
HR 2319Bills it lobbied onDaiichi Sankyo, Inc. named HR 2319, “Women and Lung Cancer Research and Preventive Services Act of 2025”, in 10 lobbying reports.10 reports
AB 1000Bills it lobbied onDaiichi Sankyo, Inc. named AB 1000, “Health care coverage: cancer treatment”, in 7 lobbying reports.7 reports
AB 219Bills it lobbied onDaiichi Sankyo, Inc. named AB 219, “Health care coverage: cancer treatment”, in 3 lobbying reports.3 reports
SB 1307Bills it lobbied onDaiichi Sankyo, Inc. named SB 1307, “Pharmacy: pedigree”, in 3 lobbying reports.3 reports
AB 265Bills it lobbied onDaiichi Sankyo, Inc. named AB 265, “Prescription drugs: prohibition on price discount”, in 3 lobbying reports.3 reports
HR 4299Bills it lobbied onDaiichi Sankyo, Inc. named HR 4299, “Protecting Patient Access to Cancer and Complex Therapies Act”, in 3 lobbying reports.3 reports
SB 1014Bills it lobbied onDaiichi Sankyo, Inc. named SB 1014, “Pharmaceutical waste: home generated: collection”, in 3 lobbying reports.3 reports
AB 613Bills it lobbied onDaiichi Sankyo, Inc. named AB 613, “Medi-Cal: treatment authorization requests”, in 2 lobbying reports.2 reports
AB 103Bills it lobbied onDaiichi Sankyo, Inc. named AB 103, “Pharmaceuticals: marketing activities”, in 2 lobbying reports.2 reports
SB 1052Bills it lobbied onDaiichi Sankyo, Inc. named SB 1052, “Health care coverage”, in 2 lobbying reports.2 reports
AB 463Bills it lobbied onDaiichi Sankyo, Inc. named AB 463, “Pharmaceutical Cost Transparency Act of 2016”, in 2 lobbying reports.2 reports
SB 17Bills it lobbied onDaiichi Sankyo, Inc. named SB 17, “Health care: prescription drug costs”, in 2 lobbying reports.2 reports
SB 727Bills it lobbied onDaiichi Sankyo, Inc. named SB 727, “Medical waste: pharmaceutical product stewardship program”, in 2 lobbying reports.2 reports
AB 2821Bills it lobbied onDaiichi Sankyo, Inc. named AB 2821, “Drug marketing: gifts”, in 2 lobbying reports.2 reports
SB 1270Bills it lobbied onDaiichi Sankyo, Inc. named SB 1270, “Pharmacy: Electronic Pedigree Task Force”, in 2 lobbying reports.2 reports
SB 1100Bills it lobbied onDaiichi Sankyo, Inc. named SB 1100, “Continuity of care”, in 2 lobbying reports.2 reports
AB 2039Bills it lobbied onDaiichi Sankyo, Inc. named AB 2039, “Solid waste: home-generated sharps”, in 2 lobbying reports.2 reports
SB 961Bills it lobbied onDaiichi Sankyo, Inc. named SB 961, “Health care coverage: cancer treatment”, in 2 lobbying reports.2 reports
SB 1010Bills it lobbied onDaiichi Sankyo, Inc. named SB 1010, “Health care: prescription drug costs”, in 2 lobbying reports.2 reports
AB 2690Bills it lobbied onDaiichi Sankyo, Inc. named AB 2690, “Product liability actions: prescription pharmaceutical products”, in 2 lobbying reports.2 reports
AB 1977Bills it lobbied onDaiichi Sankyo, Inc. named AB 1977, “Tribal gaming: compact amendment ratification”, in 2 lobbying reports.2 reports
S 1862Bills it lobbied onDaiichi Sankyo, Inc. named S 1862, “ORPHAN Cures Act”, in 2 lobbying reports.2 reports
SB 790Bills it lobbied onDaiichi Sankyo, Inc. named SB 790, “Dreissenid mussel infestation prevention: grants”, in 2 lobbying reports.2 reports
ACR 59Bills it lobbied onDaiichi Sankyo, Inc. named ACR 59, “Relative to Thrombosis Awareness Month”, in 2 lobbying reports.2 reports
AB 1512Bills it lobbied onDaiichi Sankyo, Inc. named AB 1512, “Opioid Addiction Prevention and Rehabilitation Act”, in 2 lobbying reports.2 reports
SB 48Bills it lobbied onDaiichi Sankyo, Inc. named SB 48, “Community development: healthy food choices”, in 1 lobbying report.1 report
AB 871Bills it lobbied onDaiichi Sankyo, Inc. named AB 871, “Hypertension and diabetes”, in 1 lobbying report.1 report
AB 889Bills it lobbied onDaiichi Sankyo, Inc. named AB 889, “Health care coverage: prescription drugs”, in 1 lobbying report.1 report
SB 900Bills it lobbied onDaiichi Sankyo, Inc. named SB 900, “California Health Benefit Exchange”, in 1 lobbying report.1 report
AB 1587Bills it lobbied onDaiichi Sankyo, Inc. named AB 1587, “Personal information: pharmacy”, in 1 lobbying report.1 report
SB 341Bills it lobbied onDaiichi Sankyo, Inc. named SB 341, “Pharmaceuticals: adverse drug reactions: Drug Safety and Effectiveness Program”, in 1 lobbying report.1 report
AB 2112Bills it lobbied onDaiichi Sankyo, Inc. named AB 2112, “Prescription Record Privacy Act”, in 1 lobbying report.1 report
SB 605Bills it lobbied onDaiichi Sankyo, Inc. named SB 605, “Santa Clara County: domestic violence”, in 1 lobbying report.1 report
SB 493Bills it lobbied onDaiichi Sankyo, Inc. named SB 493, “Pharmacy practice”, in 1 lobbying report.1 report
AB 751Bills it lobbied onDaiichi Sankyo, Inc. named AB 751, “Income and corporation tax credits: research and development”, in 1 lobbying report.1 report
SB 606Bills it lobbied onDaiichi Sankyo, Inc. named SB 606, “School district accountability”, in 4 lobbying reports.4 reports
AB 8Bills it lobbied onDaiichi Sankyo, Inc. named AB 8, “Health care”, in 4 lobbying reports.4 reports
SB 936Bills it lobbied onDaiichi Sankyo, Inc. named SB 936, “Workers' compensation: permanent disability schedule”, in 3 lobbying reports.3 reports
ACR 29Bills it lobbied onDaiichi Sankyo, Inc. named ACR 29, “Health disparities: racial and ethnic populations”, in 3 lobbying reports.3 reports
AB 2418Bills it lobbied onDaiichi Sankyo, Inc. named AB 2418, “Health care coverage: prescription drugs: refills”, in 3 lobbying reports.3 reports
SB 1563Bills it lobbied onDaiichi Sankyo, Inc. named SB 1563, “Pharmacy manufacturers: price regulation”, in 2 lobbying reports.2 reports
ACR 129Bills it lobbied onDaiichi Sankyo, Inc. named ACR 129, “Relative to cardiovascular disease”, in 2 lobbying reports.2 reports
SB 1765Bills it lobbied onDaiichi Sankyo, Inc. named SB 1765, “Pharmaceuticals: marketing practices”, in 2 lobbying reports.2 reports
AB 1178Bills it lobbied onDaiichi Sankyo, Inc. named AB 1178, “Income taxes: federal conformity: Patient Protection and Affordable Care Act: Health Care and Education Reconciliation Act of 2010”, in 1 lobbying report.1 report
SB 349Bills it lobbied onDaiichi Sankyo, Inc. named SB 349, “Health care coverage: electronic billing”, in 1 lobbying report.1 report
AB 1765Bills it lobbied onDaiichi Sankyo, Inc. named AB 1765, “Budget Act of 2003”, in 1 lobbying report.1 report
SB 1333Bills it lobbied onDaiichi Sankyo, Inc. named SB 1333, “Prescription drug reimbursement: pharmacy purchases from Canadian sources: Medi-Cal: AIDS Drug Assistance program”, in 1 lobbying report.1 report
SB 696Bills it lobbied onDaiichi Sankyo, Inc. named SB 696, “Pharmacies: prescription benefits: Medicare beneficiaries”, in 1 lobbying report.1 report
SB 922Bills it lobbied onDaiichi Sankyo, Inc. named SB 922, “Prescription drugs: manufacturer rebate and pharmacy discount program: seniors”, in 1 lobbying report.1 report
Showing 50 of 87

In the news

Reporting about the selected subject. Articles are context and do not establish a connection on this map.

Loading coverage…